Why EB-5 Investors Should Invest Today in a Direct Project at $500K

NEW YORK, NEW YORK, UNITED STATES OF AMERICA, August 31, 2021 /EINPresswire.com/ — EB5 Affiliate Network (EB5AN), a leading EB-5 consultancy, regional center operator, and fund manager, will host a free webinar, “Why Direct EB-5 Today at $500K” with guest panelist Edward Beshara, Esq., of Beshara, P.A on Thursday, September 2, 2021, at 3:00 PM EDT. Click here to register for the webinar or to watch a video recording of the webinar after the webinar takes place.

Following the sunset date of the EB-5 Regional Center Program on June 30, 2021, U.S. Citizenship and Immigration Services (USCIS) is accepting only I-526 petitions for direct EB-5 investments. Additionally, on June 22, 2021, a California magistrate judge invalidated the EB-5 Program Modernization Rule that came into effect on November 21, 2019. Consequently, the minimum investment amount for projects located in targeted employment areas (TEAs) has returned to $500,000 ($1.0 million if not located in a TEA).

To help investors make the most of the opportunity to make direct EB-5 investments of $500,000 in projects located in TEAs, the webinar addresses several frequently asked questions and provides an overview of the benefits of multi-unit direct EB-5 investments. The following questions will be covered in the webinar:

• How is a direct EB-5 investment better than a regional center investment?
• How does a direct project show 10 new jobs?
• How can I receive a return on my $500K investment?
• When will my $500K investment be returned?
• How can I evaluate immigration risk in a direct EB-5 project?
• How can I evaluate financial risk in a direct EB-5 project?
• What are multi-unit direct EB-5 investments, and what benefits do they offer?
• Will a multi-unit direct EB-5 investment diversify my immigration and financial risk?

EB5AN Managing partner Sam Silverman noted that there is likely a limited window for investing at $500,000 and encouraged prospective investors to take advantage of the opportunity while it remains available. “The EB-5 regional center program is likely to get renewed in the coming months,” said Silverman. “When it is renewed, it is highly likely that the EB-5 program’s minimum investment amount will be increased.”

“It is important to conduct due diligence on all prospective EB-5 projects, either direct or regional center, in order to make an informed investment decision that considers all financial and immigration risk aspects of the investment,” Edward C. Beshara, Esq., managing partner of Beshara, P.A., added.

Created by the U.S. Congress in 1990, the EB-5 program provides a clear pathway to permanent residency and citizenship. Tens of thousands of families from nearly every country have successfully immigrated by making qualifying investments in U.S. projects and business enterprises. The EB-5 visa is popular among people currently living abroad and those already working in the United States on nonimmigrant visas.


EB5 Affiliate Network is a national EB-5 regional center operator and consulting firm that has been trusted by 1,800+ EB-5 investors from 60+ countries. EB5AN works with direct EB-5 and regional center EB-5 project developers and sponsors to assemble high-quality EB-5 projects across the country. EB5AN also works with EB-5 investors from around the world to identify high-quality, low-risk EB-5 investments and to structure EB-5 projects for those who seek to create their own.

Beshara, P.A., is a top U.S. immigration law firm exclusively dedicated to immigration law. Their highly reputable legal services are available to EB-5 investors, regional centers, and developers. The firm is recognized as one of the top EB-5 visa-focused law firms in the U.S.

Jeremy Shackle
EB5 Affiliate Network

Source: EIN Presswire

At CAGR of 18.2% BFSI Crisis Management Market to Garner $31.15 Billion by 2027

BFSI Crisis Management Market

BFSI Crisis Management Market

PORTLAND, OREGON, UNITED STATES, August 31, 2021 /EINPresswire.com/ — As per the report published by Allied Market Research, titled, "BFSI Crisis Management Market by Component (Solution and Services), Deployment Type (On-premises and Cloud), Enterprise Size (Large Enterprises and Small & Medium Enterprises (SMEs)), and Application (Disaster Recovery & Business Continuity, Risk & Compliance Management, Crisis Communication, Incident Management & Response, and Others), and End User (Banks, Insurance Companies, and Others) : Global Opportunity Analysis and Industry Forecast, 2020–2027" the global BFSI crisis management market was accounted for $8.46 billion in 2019, and is expected to garner $31.15 billion by 2027, registering a CAGR of 18.2% from 2020 to 2027.

Increase in dependency on crisis management software & solutions among financial institutions and rise in adoption of crisis management solutions among the BFSI sector have boosted the growth of the global BFSI crisis management market. On the contrary, complicated management of networks and data theft & cybersecurity concerns hinder the market growth. However, untapped potential in developing countries would open new opportunities in the coming years.

Download Free Sample Report (Get Detailed Analysis in PDF – 265+ Pages): https://www.alliedmarketresearch.com/request-sample/11470

Key benefits for stakeholders

The study provides in-depth analysis of the global BFSI crisis management market share along with current & future trends to illustrate the imminent investment pockets.
Information about key drivers, restrains, and opportunities and their impact analysis on the BFSI crisis management market size are provided in the report.
Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
An extensive analysis of the key segments of the industry helps to understand the global BFSI crisis management market trends.
The quantitative analysis of the global BFSI crisis management market from 2020 to 2027 is provided to determine the market potential.

Covid-19 scenario:

The pandemic and lockdown across several region led to rise in use and adoption of online and digitalized financial services across the globe.
Moreover, several countries imposed strict lockdowns to curb the spread of the virus. Thus, several market players offered an advanced platform for managing uncertain incidents, risks, and cyber protection solutions for financial institutes.

The global BFSI crisis management market is segmented on the basis of component, deployment type, enterprise size, application, end user, and region.

Based on component, the services segment is projected to register the highest CAGR of 19.7% during the forecast period. However, the solution segment dominated the market in 2019, contributing to more than two-thirds of the market.

Interested to Procure the Data? Inquire here @ https://www.alliedmarketresearch.com/purchase-enquiry/11470

By application, the risk & compliance management segment would register the highest CAGR of 19.3% from 2020 to 2027. However, the incident management & response segment held the lion’s share in 2019, accounting for nearly two-fifths of the market.

The global BFSI crisis management market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across Asia-Pacific would showcase the highest CAGR of 20.4% during the forecast period. However, the market across North America generated the largest share in 2019, holding more than one-third of the market.

Get detailed COVID-19 impact analysis on the BFSI Crisis Management Market: https://www.alliedmarketresearch.com/request-for-customization/11470?reqfor=covid

The global BFSI crisis management market includes an in-depth analysis of the prime market players such as 4C Strategies, Everbridge, CURA Software Solutions, Konexus, IBM, MetricStream Inc., LogicGate, Inc., Noggin, NCC Group, and SAS Institute Inc.

David Correa
Allied Analytics LLP
+15034461141 ext.
email us here
Visit us on social media:

Source: EIN Presswire


Eden Biologics, Inc.

Eden Biologics, Inc.

總部位於台灣新竹的生技公司伊甸生醫宣布任命李世雄博士(Dr. Steve Lee)為新任執行長與董事會成員。李博士對於生物製劑研究、生物製程開發、技術營運、業務發展、策略規劃和商業製造方面,有30多年傑出經驗。李博士曾帶領美國和亞洲的生技新創與大型生物製藥集團轉型為高績效組織。

新竹, 台灣, September 1, 2021 /EINPresswire.com/ — 總部位於台灣新竹的前瞻生技公司伊甸生醫,於 9 月 1日宣布任命在生技領域極具經驗與創業領導魄力的成功經理人李世雄博士(Dr. Steve Lee),為新任執行長與董事會成員,即刻生效。李博士是一位備受尊敬的執行長和業界領袖,在規範嚴謹的環境和新興市場中,對於生物製劑研究、生物製程開發、技術營運、業務發展、策略規劃和商業製造方面,有30 多年傑出經驗。李博士曾帶領美國和亞洲的生技新創與大型生物製藥集團轉型為高績效組織。


作為美國BioGENEXUS, LLC的創辦人暨前執行長,李博士開發顛覆性創新和突破性製造技術平台,同時提供全球生物技術諮詢服務。而今,李博士將其豐富業界經驗、強大領導力和熱情帶進伊甸生醫,以期在亞洲及美國擴大伊甸創新與具成本效益的生物製劑開發平台和商業製造聯盟。創辦BioGENEXUS之前,李博士是印度製藥公司 Dr. Reddy's Labs (DRL) Biologics 生物製劑技術部門全球負責人和新加坡分公司執行長。該公司是亞洲領先生物相似藥廠之一,李博士負責四款商業生物製劑生產,並協助六款開發中之生物相似藥。在加入DRL之前,李博士是中國綠葉製藥集團生物製劑業務的全球負責人,該集團收購了新加坡政府創立的生技公司 A-Bio Pharma,李博士當時為該公司執行長。

回亞洲服務之前,李博士是美商必治妥施貴寶公司(BMS)的副總裁兼製程開發與製造部總經理,負責領導紐約雪城的製造部門和製程開發團隊,開發並推出廣泛的蛋白質療法和後期開發生物製劑。在嚴格的時間限制下,李博士為 BMS 生物製劑特許經營成立了一個高績效團隊以開發永續基礎設施,並獲得 FDA 批准推出首款BMS 自行開發的自體免疫生物製劑 Orencia®。他亦曾擔任生物製劑開發卓越中心負責人,帶領跨部門團隊在麻州建立自有大型細胞培養設備(6座20,000升生物反應器),使BMS有效擴展版圖並成為今日腫瘤免疫學巨頭。加入 BMS 之前,李博士還曾在兩家全球製藥公司工作:默克和羅氏藥廠之美國分公司。李博士在紐澤西州的兩個默克實驗室擔任過多個職位,負責開發各種疫苗和生物衍生療法製程,包括推出抗真菌劑 Cancidas®;而於賓州的默克製造部門,他建立並帶領一個整合無菌製程、工程和技術服務團隊,以支持所有商業生物製劑並推出新型疫苗。


欲知詳情,歡迎e-mail至 partner@edenbiologics.com

Yen Hsieh
Eden Biologics, Inc.
+886 3 658 3899
email us here
Visit us on social media:

Source: EIN Presswire

Eden Biologics Introduces New Chief Executive Officer, Dr. Steve Lee

Eden Biologics, Inc.

Eden Biologics, Inc.

Eden Biologics, a leading global biotechnology company based in Taiwan, announced the appointment of Dr. Steve Lee as the new CEO and Director of the Board.

HSINCHU, TAIWAN, September 1, 2021 /EINPresswire.com/ — Eden Biologics, Inc., a leading global biotechnology company based in Hsinchu, Taiwan, announced on September 1st, the appointment of Dr. Steve Lee, an accomplished biotech executive with broad experience and entrepreneurial leadership, as the new CEO and Director of the Board, effective immediately. Dr. Steve Lee is a highly respected CEO and global business leader with a distinguished track record in biologics research, bioprocess development, technical operations, business development, strategic planning, and commercial manufacturing in a highly regulated environment and emerging markets for over 30 years. Specifically, Dr. Lee has led changes in transforming companies into high-performance organizations in biotech startups and large biopharmaceutical groups in the United States and Asia.

James Huang, Chairman of the Board of Eden Biologics: “We are very excited to welcome Dr. Steve Lee as Eden Biologics’ new Chief Executive Officer. He is a well-recognized, proven scientific leader at a time when Eden is in excellent position to accelerate growth and innovation and I am very pleased to welcome Dr. Lee as our new CEO. Dr. Lee has excelled at strategic leadership and efficient operational execution throughout his career and is well-positioned to continue to enhance Eden’s thriving biologics development while maintaining a hyper focus on our vision to make affordable, high-quality biological medicines for all patients in need. His invaluable commercial expertise in the manufacturing of both therapeutic biologics and novel vaccines amplifies the company’s strategic direction and I’m ecstatic to have him lead Eden and take advantage of all future global market opportunities.”

Previously the CEO and Founder of BioGENEXUS, LLC, Dr. Lee developed disruptive innovation and breakthrough manufacturing technology platforms while providing biotech consulting services globally. Now he brings his extensive biotech industry experience, strong leadership and passion to Eden Biologics with hopes of expanding Eden’s innovative, cost-effective biologics development platform and commercial manufacturing alliances in both Asia and the US. Before founding his own firm, Dr. Lee was the Global Head, Biologics Technical Operations and CEO of Singapore Operations for Dr. Reddy’s Labs (DRL) Biologics, one of Asia’s leading biosimilar developers and was responsible for overseeing the manufacturing four commercial biologics while supporting six biosimilars in development. Before Dr. Reddy’s Labs, Dr. Lee was the Global Head, Biologics Business of Luye Pharma Group, a China-based pharmaceutical company, which acquired A-Bio Pharma in Singapore, a pioneering biotech company founded by Singapore government, where he served as CEO.

Prior to his return to Asia, Dr. Lee was Vice-President and General Manager, Process Development and Biologics Manufacturing, Bristol-Myers Squibb Company (BMS) where he was responsible for leading the Syracuse, New York Manufacturing and Process Development groups, developing and launching a wide range of protein therapeutics and late-stage development biologics. Most impressively, under severe time constraints, Dr. Lee established a high-performance team to develop sustainable infrastructure for the BMS biologics franchise and obtained FDA approval to launch the very first BMS internally developed biologic, Orencia® for autoimmune diseases. He also served as the Head of Biologics Development Center of Excellence and led a cross functional team to build its own large-scale commercial Cell Culture Manufacturing Facility (6×20,000L bioreactors) in Devens, MA, which enabled BMS to expand effectively as the immuno-oncology giant today. Prior to joining BMS, Dr. Lee also worked for two global pharmaceutical companies: Merck & Co., Inc. and Hoffmann-La Roche, Inc., both located in the US. At Merck, Dr. Lee held several positions of increasing responsibilities at both Merck Research Laboratories in Rahway, NJ, where he developed various bioprocesses for vaccines and biologically derived therapeutics including launching antifungal agent, Cancidas®; and Merck Manufacturing Division in West Point, PA, where he built and led an integrated sterile process, engineering and technical services group to support all commercial biologics and introduced novel vaccines.

Dr. Lee received his Ph.D. in Biochemical Engineering from the Massachusetts Institute of Technology (MIT); M.S. in Chemical Engineering from The University of Michigan; B.S. in Agricultural Chemistry from National University of Taiwan.

About Eden Biologics, Inc.
Eden Biologics is a biopharmaceutical company established in 2012 and after a transformation under new executive leadership led by James Huang, Chairman and CEO (also Managing Director of KPCB China), Eden continues to focus on three biotech sectors: 1) Accelerating the development programs for clients through the provision of Contract Development and Manufacturing Services (from cell line development to commercial manufacturing with regulatory filing support; 2) Developing a Proprietary Biosimilar Pipeline; and 3) Collaborating & Licensing of New and Innovative Biologics.
For more information, please contact us at partner@edenbiologics.com

Yen Hsieh
Eden Biologics, Inc.
+886 3658-3899
email us here
Visit us on social media:

Source: EIN Presswire


TORONTO, ONTARIO, CANADA, August 31, 2021 /EINPresswire.com/ — Well Told Inc. ("Well Told" or the "Company") and Agau Resources, Inc. ("Agau") are pleased to announce the closing of the Company’s private placement comprised of 1,945,001 subscription receipts of the Company (the “Subscription Receipts”) at a price of $2.84 per Subscription Receipt (the “Offering Price”) for aggregate gross proceeds of $5,523,803 (the "Financing"), in accordance with, among other things, the provisions of an agency agreement dated August 24, 2021 among Well Told, Agau and a syndicate of agents led by Canaccord Genuity Corp. (the “Lead Agent”) and including Echelon Wealth Partners Inc. and Richardson Wealth Limited (collectively with the Lead Agent, the “Agents”).

The net proceeds of the Financing (the "Escrowed Funds") have been deposited in escrow pursuant to the terms of a subscription receipt agreement (the "Subscription Receipt Agreement") dated August 24,2021 between Well Told, the Lead Agent and Computershare Trust Company of Canada, as the subscription receipt agent. The Escrowed Funds will be held in escrow pending satisfaction or waiver (to the extent waiver is permitted) of all of the escrow release conditions pursuant to the terms of the Subscription Receipt Agreement (the "Escrow Conditions") including, but not limited to, the Company receiving all applicable regulatory approvals and completion of the previously announced go-public transaction of Well Told by way of a proposed reverse take-over transaction of Agau by Well Told, with the resulting company (the "Resulting Issuer") to be renamed “The Well Told Company Inc.” (the "Transaction"), as more particularly described the news release of Agau dated August 12, 2021.

Upon satisfaction of the Escrow Conditions, the Escrowed Funds will be released to the Company, and each Subscription Receipt will automatically convert into one unit (a "Unit") of Well Told, without payment of any additional consideration and without further action on the part of the holder thereof. Each Unit is comprised of one common share of Well Told (a "Well Told Share") and one-half of one Well Told Share purchase warrant of Well Told (each whole warrant, a "Well Told Warrant"). Each Well Told Warrant will be exercisable to acquire one additional Well Told Share for a period of 24 months following the date the Escrow Conditions are satisfied at a price of $3.83 per Well Told Share, subject to certain adjustment in certain events and the right of Well Told to accelerate as set out in the warrant indenture dated August 24, 2021 between Well Told and Computershare Trust Company of Canada, as warrant agent. Pursuant to the Transaction, for no additional consideration, (i) each Well Told Share will be automatically exchanged in the Transaction for 11.36 common shares of the Resulting Issuer, and (ii) each Well Told Warrant is to be immediately exchanged in the Transaction for 11.36 warrants of the Resulting Issuer pursuant to the terms of the amalgamation agreement dated August 12, 2021 among Well Told, Agau and 2835270 Ontario Ltd., a wholly-owned subsidiary of Agau.

If the Escrow Conditions are not satisfied on or prior to 5:00 p.m. (Toronto Time) on December 16, 2021, the Escrowed Funds will be returned to the subscribers and the Subscription Receipts will be cancelled and be of no further effect or value.

CEO Monica Ruffo stated: "We are thrilled to complete this financing which will enable us to solidify our presence in Canada and pursue our growth strategy in the United States, a very large and growing functional wellness market. We are excited about the future and look forward to updating our shareholders as we begin the next chapter of our growth.

About Agau Resources, Inc.

Agau Resources, Inc. is a mineral exploration company with no current activities or operations.

About Well Told Inc.

Well Told Inc. is a female founded, emerging plant-based wellness company that formulates, develops, distributes and sells a variety of supplements, remedies and other functional wellness products. Founded by serial entrepreneur and award-winning leader Monica Ruffo, it was after undergoing treatment for breast cancer, and deciding to take her health into her own hands that she discovered the lack of transparency and availability of clean, plant-based formulations in the wellness industry. Well Told Inc. is on a mission to make the world a healthier place through plants. All the unique formulations are free of synthetics and fillers and offer scientifically proven results.

For more information please contact:

Agau Resources, Inc.:

Binyomin Posen
Chief Executive Officer and Director
Phone: (416) 481-2222 x 246
E-mail: bposen@plazacapital.ca

Well Told Inc.:

Edge Communications Group
Phone: (778) 400-1608
E-mail: invest@welltold.com

All information contained in this news release with respect to Well Told was supplied by Well Told for inclusion herein and the Company has relied on the accuracy of such information without independent verification.

The completion of the Transaction is subject to a number of conditions, including listing of the Resulting Issuer Shares on the TSX Venture Exchange. There can be no assurance that the Transaction will be completed as proposed or at all.

Investors are cautioned that, except as disclosed in by the Company in connection with the Transaction, any information released or received with respect to the Transaction may not be accurate or complete and should not be relied upon. Trading in the securities of Agau should be considered highly speculative.

Not for distribution to United States newswire services or for the dissemination in the United States.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but are not limited to, information concerning the Transaction, expectations regarding whether the Transaction will be consummated, including whether conditions to the consummation of the Transaction will be satisfied, expectations for the effects of the Transaction or the ability of the Resulting Issuer to successfully achieve business objectives, expectations regarding the completion and availability of financing, and expectations for other economic, business, and/or competitive factors.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward- looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice.

Binyomin Posen
Agau Resources, Inc.
+1 (416) 481-2222 x 246

Source: EIN Presswire

GCSEN Held Its First-Ever “MVP Demo Day”

We are moving the world to a better place through Social Entrepreneurship!


MVP Presenters & Social Entrepreneur Amy Wu

Program graduates, alumni, and GCSEN consultants had the opportunity to present their business ideas and do a demonstration of their products and services.

KINGSTON, NEW YORK, UNITED STATES, August 31, 2021 /EINPresswire.com/ — GCSEN Held Its First-Ever “MVP Demo Day”!

On July 14, 2021, The GCSEN Foundation held its first-ever Minimum Viable Product (MVP) Demo Day where program graduates, alumni, and GCSEN consultants had the opportunity to present their business ideas and do a demonstration of their products and services.

During the GCSEN MVP Demo day, the primary benefit was a real world experience for peer-to-peer market feedback with practice in pitching, showing, telling, and selling. This was also an opportunity to create the gift of new friendships, business support, customer connections, real-world advice and next level input in a highly supportive environment. This keeps with the requests of GCSEN Students and alumni when they say, “Inspire me! Teach me! Support me!”

Each presenter first had 10 minutes for a traditional angels pitch deck format overview, followed by a 3-minute group Q&A session and then an active 25 minutes demonstration of their MVP offer. Each presenter created a “Lesson Plan” for their MVP including a practical demo where they had: an audience participate in a “do now” activity to experience the MVP service and/or product. At the end of their demonstration, the audience of GCSEN Faculty, Students, Interns and Alumni, Fellow Business Coaches, Mentors and VIP Observers provided constructive feedback. Finally, each presenter received up to (3) GCSEN Club THEOS alumni business contacts to help each other succeed!

MVP Demo Day Presenters:

Winslow Robinson – “Achilles Heal”, W ‘20
Suicide Prevention program using modern therapy, drama and theatre techniques

Ervin Williams – “Psi7 ”, W‘24
Engaging Board community games based on fostering greater understanding of historical events and cultures across the world

Ariel Ferreira – “South Coast Building Initiative”, W ‘24 A(B) Corporation dedicated to providing marginalized groups with construction industry carpentry skills

Shanai Williams – “Be Heard”, W ‘23
An education organization dedicated to giving a voice to children through afterschool programs and meals

Flor Najera – “Najera Studios” – Marketing and Public Relations Services, Marist MA ‘21, SUNY New Paltz BA ‘19

Heather Rotman – “Kindness Collective”,
W ‘17, An kindness promotion and anti-bullying middle school education program

Zara Salmon – “CRAVE Infused”, W’18
Homemade and plant-based skin care products and body butter creams

Kyle McNicoll – “Puppy Love Breeders”,W’16, Golden Lab breeding
And Adoption Dog Center

David Cagan – “Common Sense Consulting
Business”, Cornell ‘83, Performance skills through mindfulness techniques

Farough Saw- St. Peter’s University Guarani Business School, ‘21, “Agro-Forward”- a micro-farm and local economy initiative for North Africa

Guest Presenters:

Amy Wu, an Award-winning journalist, Director of the documentary film From Farms to Incubators, and Communications Director for the Hudson Valley’s Novo Foundation's Farm Hub

Chris Hewitt – “Hudson Valley CurrentLocal Currency, Tilda’s Kitchen-Farm to Community Cafe and The Livelihood Magazine”, GCSEN ‘15

GCSEN developed this new program offering as a next step for its Club THEOS Alumni Community "to go to market" especially for graduates of our national pilot college campus program partner Wheaton College (MA) – Social Entrepreneur Launch Program. Building on the momentum gained from GCSEN’s 4P SE Social Venture BootCamp for Wheaton students, this MVP Day builds on the impact of GCSEN’s programs and support services thru the Wheaton Social Entrepreneurship Launch Program for the Spring Semester, and the students Social Venture Statement of Intent Capstone.

Our goal is to accelerate more GCSEN 4P Social Ventures into the market and begin the positive cycle of value creation, cash flow and voluntary exchange while getting practical customer feedback.

The design intent is to be supportive in a practical, practitioner-focused, affordable and actionable way to help our GCSEN program graduates "Get to WOW!" with their GCSEN 4P Social Ventures for the benefit of People, Profit, Planet, and Place.

For more information on GCSEN go to www.GCSEN.com.

Press Contact- Mike Caslin, GCSEN Founder/CEO, Mike@gcsen.com, cell- 001-212-444-2071 or GCSEN Media Relations Coordinator Junior Consultant Flor Najera (W’18), flor@gcsen.com


Michael Caslin
GCSEN Foundation
+1 212-444-2071
Visit us on social media:

Source: EIN Presswire

Seeking Zen in a Post-Pandemic 3PL Market

MILWAUKEE, WISCONSIN, UNITED STATES, August 31, 2021 /EINPresswire.com/ — According to Armstrong & Associates, Inc. (A&A’s) newest report, “Seeking Zen: A Post-Pandemic 3PL Market – Latest Third-Party Logistics Market Results and Predictions for 2021 Including Estimates for 190 Countries” the volatile 2020 U.S. COVID-driven Third-Party Logistics (3PL) Market created growth opportunities for Third-Party Logistics Providers (3PLs) with strong carrier management, e-commerce, and air freight forwarding capabilities, while other 3PLs did not fare as well. After having a lackluster 2019 when we saw a year-over-year decline in transportation activity as import tariffs took hold, we awoke to a pandemic nightmare in March of 2020 with vast economic shutdowns. There was no time like the present for logistics expertise, and 3PL prevailed as an essential industry.

Leading all 3PL segments for revenue growth in 2020 was International Transportation Management (ITM) which consists of air and ocean freight forwarding, customs brokerage, and complementary value-added services. Air freight revenues swelled in 2020 with the pandemic and extraordinary demand for PPE. With commercial passenger aircraft making up approximately 40% of total air cargo capacity, the pandemic upended air freight forwarding, and rates surged albeit on lower overall volumes.

Overall, ITM realized a 19.2% gross revenue gain in 2020 expanding to $70 billion. While having a lower growth rate than overall gross revenue, due to a tight carrier capacity market, net revenue increased a healthy 11.4% to $24.6 billion.

The asset-heavy Dedicated Contract Carriage (DCC) 3PL segment had the second highest net revenue growth of the four 3PL segments with just 0.3% to $20 billion. Gross revenue declined 2%. The negative effect of COVID made 2020 a volatile and lower-volume year versus 2019 when DCC net revenues grew 12.1%.

The non-asset based Domestic Transportation Management (DTM) segment includes Freight Brokerage which is 83% of segment revenues and Managed Transportation which accounts for 17%. In 2020, 3PLs scrambled to find carrier capacity to meet shipper demand. Gross revenue increased 9.9% to $91.2 billion, but net revenue decreased 1.8% to $13.2 billion as volatility in motor carrier capacity quickly increased spot market rates compressing segment gross margins by 1.7%.

Rapid growth in e-commerce fulfillment could not offset the loss of business-to-business related activity as overall revenues for the Value-Added Warehousing and Distribution (VAWD) 3PL segment sagged in 2020 versus its 9% growth 2019. VAWD net revenues declined 1.1% to $35.7 billion.

Total 3PL segment net revenues (gross revenues less purchased transportation) grew 2.1% to $93.5 billion reflecting gross margin compression due to a volatile carrier sourcing market and transportation management 3PLs spending more to secure hard-to-find carrier capacity. The overall gross margin for all segments declined from 44% to 41%.

Global Third-Party Logistics (3PL) Market revenues reached $962 billion in 2020 resulting in a meager 0.1% increase over 2019 versus the U.S. 3PL Market which saw 8.8% year-over-year growth. As with the U.S., the ITM segment led the way due to COVID-19 response.

For more information on A&A’s newest report, “Seeking Zen: A Post-Pandemic 3PL Market – Latest Third-Party Logistics Market Results and Predictions for 2021 Including Estimates for 190 Countries” and other market research, please visit: http://www.3plogistics.com/product-category/guides-market-research-reports/.

Armstrong & Associates, Inc. (A&A) was established in 1980 to meet the needs of a newly deregulated domestic transportation market. Since then, through its leading Third-Party Logistics (3PL) market research and history of helping companies outsource logistics functions, A&A has become an internationally recognized key resource for 3PL market information and consulting.

A&A’s mission is to have leading proprietary supply chain knowledge and market research not available anywhere else. As proof of our continued work in supporting our mission, A&A’s 3PL market research is frequently cited in media articles, publications, and securities filings by publicly traded 3PLs. In addition, A&A’s email newsletter currently has over 88,000 subscribers globally.

A&A’s market research complements its consulting activities by providing continually updated data for analysis. Based upon its unsurpassed knowledge of the 3PL market and the operations of leading 3PLs, A&A has provided strategic planning consulting services to over 30 3PLs, supported 24 closed investment transactions, and provided advice to numerous companies looking to benchmark existing 3PL operations or outsource logistics functions.

Armstrong & Associates, Inc.
10401 West Lincoln Avenue, Suite 207
Milwaukee, WI 53227 USA
Phone: +1-414-545-3838 Fax: +1-414-545-3906
Website: www.3PLogistics.com

Evan Armstrong
Armstrong & Associates, Inc.
email us here

Source: EIN Presswire

Decarbonization: The transition has barely begun; By Graeme Baker, Co-Portfolio Manager, Ninety One Global Environment

Photo of Graeme Baker, Co-Portfolio Manager, Global Environment for Ninety One

Graeme Baker, Co-Portfolio Manager, Global Environment for Ninety One

Understanding how the flow of capital can help solve the climate crisis could be the single most important action of our generation.

It's our hope these recent reports will galvanize quicker political action and leave the investment industry in no doubt that understanding the flow of capital can help solve the climate crisis…”

— Graeme Baker, Co-Portfolio Manager for Ninety One

NEW YORK, NEW YORK, UNITED STATES, August 31, 2021 /EINPresswire.com/ — The summer of 2021, with its record-breaking heat waves, devastating floods and wildfires, has vividly illustrated the realities of climate change. This season has served as an uncomfortable reminder that the climate crisis has still barely been addressed, and it is clear that we urgently need to do much, much more as a global economy. This also means that tackling this problem presents us with significant growth opportunities.

We’re not moving fast enough
The 16th edition of the World Economic Forum's Global Risks Report reminds us, once again, that failure to take action on climate change is the biggest risk that we face as a species. In fact, it’s the top risk not just by impact but also by likelihood.

The UN IPCC’s Sixth Assessment Report confirms with science what we have all feared to be true – that humanity has had an ‘unequivocal’ influence on global warming and that widespread and rapid changes to the climate system have already begun. Every 0.1 degree of warming matters and, unless urgent action is taken to decarbonize our global economy, global warming of 1.5°C and even 2°C (vs pre-industrial levels) will be exceeded in the current century.

The findings of both reports are alarming in themselves, while also underscoring that we need to act, and that we need to act quickly.

Five years after the Paris Agreement (COP21), in which political leaders pledged Nationally Determined Contributions (NDCs) to curb greenhouse gas emissions, many of those NDCs are up for renewal with leaders needing to pledge ahead of COP26. The UN Interim Synthesis Report released in February this year states that many regions’ pledges and NDCs have not been ambitious enough, potentially yielding the equivalent of a mere 0.5% reduction in emissions from 2010 to 2030, when this figure should be closer to 45%. So as we head towards COP26, we hope to see more positive news and announcements from many countries around the world.

Once-in-a-lifetime investment opportunities abound
The scale of the immense change in how we function as economies means that we have a rare opportunity to invest to support the step change needed. The latest International Energy Agency (IEA) Report highlights that a four-fold increase in wind, solar and renewable energy capacity is required by 2030 from where we are today. It also states that, by 2030, the number of electric cars on the road needs to increase by 18 times and the annual battery production for electric vehicles by 41 times.

This means that significantly more capital must be spent in these areas, and the focus needs to shift to sustainable supply chains. The report further states that we need to spend over $4 trillion by 2030 if we are to have any hope of getting to net zero – a huge increase from the just under $1 trillion that’s been spent over the last few years.

Can we eat our way to net zero?
At Ninety One, we believe this provides an exciting, long-term, potentially once-in-a-lifetime structural growth opportunity for investors. An important point to highlight is that the IEA Report focuses only on the energy system, which accounts for about two-thirds of global carbon emissions. There are additional areas that we believe should be prioritized, and one of these is the future of food.

The global population is expected to increase to nine billion by 2050. To meet the demand associated with this number of people, food production will need to increase by 70%. What’s more, we need to achieve this in a carbon-efficient way, with less land and in increasingly challenging environmental conditions. Almost 20% of global carbon emissions are derived from ‘growing things’ for consumption – whether that’s plants or animals – and it is becoming quite clear that massive change in agriculture, livestock and the supply chain is urgently needed to decarbonise this sector across the world.

One area where we have carried out significant research is the decarbonization of meat. We see significant potential for growth in plant- and cellular-based meat because they have significantly lower carbon emissions relative to what they are replacing within the meat supply chain. We expect this market to potentially grow from tens of billions of dollars currently to over $300 billion by 2035.

Other opportunities include the natural-based products and enzymes used in plant- and cellular-based meat alternatives; and biochemicals and biosurfactants. Producers of these are helping to replace petrochemicals in many different industries, for example, the use of natural products to improve crop yields and resource efficiency when growing plants for consumption.

It’s no longer responsible or even viable to maintain current forms of agriculture, infrastructure, urban planning, land use, and economic development. Global movements on climate change have put pressure on leaders to take action and address the climate crisis like never before, and what is decided by their pledges ahead of COP26 will be key to how effective countries are at tackling the climate crisis in the next ten years.

It is our sincere hope that the findings of recent reports will galvanize far quicker political action, and leave the investment industry in no doubt that understanding how the flow of capital can help solve the climate crisis will be the single most important action of our generation.

All investments carry the risk of capital loss. The information contained in this press release is intended primarily for journalists and should not be relied upon by private investors or any other persons to make financial decisions. Furthermore, the material contained herein is for informational purposes only and should not be construed as an offer, or solicitation of an offer, to buy or sell securities either generally or in any jurisdiction where the offer or sale is not permitted. Offers are made only by prospectus or other offering materials and upon an investor meeting certain suitability standards and any other applicable requirements as required by law.

Kimberly Weinrick
Ninety One

Source: EIN Presswire

The Sales Control Plan Sets Standard for Sales Enablement

SalesPulse Illustration from Sales Control Plan Mangement

Accurate Training Trends and Efficiency Ratings from CRM

The sales control plan management platform is the solution for all B2B selling challenges.

Sales leaders usually hire to solve talent problems, and choose a brand of CRM to solve process problems. Two of the biggest mistakes made when managing a sales force.”

— Edward Henry

TORONTO, ONTARIO, CANADA, August 31, 2021 /EINPresswire.com/ — Imagine if you were able to see exactly where every opportunity is at in your pipeline. We have experienced those long-winded sales stories that still did not add up to a closed sale, or even determined what needed to be closed. Sales managers are in the dark when it comes to seeing where the opportunities are in the organization’s pipeline. This has been the reason for most of the sales waste that many companies struggle to identify.

As a leader we want those around us to succeed. It reflects well on our own efforts, but more importantly, on the organization. Sales Training is an excellent way of building relationships and supporting your team with all the necessary resources and tools that they require to succeed. You can easily create goodwill while simultaneously creating accountability amongst your team.

Sales Control Plan Management is a management and training resource that provides sales leaders, and the salesforce with everything they need to manage, train, onboard, and reference. It is the ultimate resource for sales intelligence. It is time to make real time solutions in real time.


Training & Adoption

As the world changes around us, so has the way we learn and expand our skills. Sales Control Plan Management’s sales waste assessment identifies the sales waste and sales operation deficiencies in the sales organization. The results of the assessment provide the accurate roadmap to achieve highest standard for sales training and CRM adoption success.

Sales Control Plan

There are so many elements to manage when it comes to supervising a sales force. Sales Control Plan allows you to work with transparent metrics that help you to clearly see everything in your entire pipeline. You know exactly where to spend you time and resources for optimum sales management success. After implementation of baseline metrics, Sales Control Plan Management will provide the workflow automation that ensures your sales reps do not miss any opportunities.

There has never been a better management system that integrates with all brands of CRM to provide the highest level of accountability and sales intelligence throughout the entire sales force.

There is no more training on random selling methodologies or skill development. Sales Control Plan provides accurate training metrics which are accessed from actual CRM activity. Companies will eliminate massive training waste by training specifically in the area where the sales rep or sales force is struggling. Sales Control Plan solves every organization’s most costly selling challenges.

Benefits of Sales Control Plan Management

• Improved Customer Engagement
• Reduced Sales Waste
• Eliminate opportunities from going COLD!
• Sales Force Accountability – Management Accountability – Customer Accountability
• No more missed follow up calls
• No more missed deadlines on sales deliverables
• No more inactivity
• Complete pipeline visibility
• Simple onboarding of new hires saving money on training and resources.
• Progressive evaluation and sales analytics that produce accurate training scope based on CRM and selling practices.
• Real Time is REAL TIME
• CRM integration to make sure that learning requirements are triggered based on CRM performance metrics.
• Reduce and eliminates false reporting in CRM.
• Triggered emails specific to the customers sales stage, and engagement to communicate relevant requests, or notices where the sales representative has lost engagement due to inactivity or missed follow up.

Edward David Henry
Edward Henry Company
+1 647-725-7575
email us here

Source: EIN Presswire

Kingsview Investment Management Launches Opportunity Income Strategy

Opportunity Income Aims To Help Investors Meet Overall Fixed Income Goals

We respect the importance of keeping a longer-term outlook while still protecting against the risks of tomorrow.”

— Mitch Ehmka, Director of Trading and Co-Portfolio Manager

CHICAGO, IL, USA, August 31, 2021 /EINPresswire.com/ — Kingsview Investment Management ("KIM") today announced the launch of their Opportunity Income (OI) strategy, which was designed with the goal of optimizing allocations across various fixed income sectors. Opportunity Income's primary objective is to deliver a better risk-adjusted return than the aggregate bond benchmark by analyzing spreads between short and long-term U.S. treasury bonds.

Investors seeking a "permanent" active fixed income allocation to balance the risks of investing in equities may find Opportunity Income of interest. It is a potential solution for investors wondering what to do right now in the fixed income portion of their portfolios, but might be worried about key bond risks such as inflation, rising rates, or even economic uncertainty.

"'We're excited to share this strategy with investors because we understand how challenging fixed income can be to invest in at times like this." – Paul Nolte, Senior Vice President and Co-Portfolio Manager

Opportunity Income's philosophy reflects KIM's belief that a historically informed, fundamental approach to core fixed income investing can provide long-term superior risk-adjusted return. The strategy was designed with these elements in mind:

Passive ETF Selection – Investments consist of Core Fixed Income exposures derived via low-cost ETFs like that of the benchmark at times but can span a variety of classifications, quality, and duration. At times, the portfolio may take key exposures away from the benchmark in an attempt to optimize for the current environment.

Risk Management – Opportunity Income is an overall risk framework, helping to guide fixed income asset allocation throughout the interest rate & credit cycle by analyzing current treasury spread positioning.

Consistency – Fixed income asset class risks, returns and correlations may vary depending on where you are in this cycle. Historically there are possibly more opportune times to overweight or underweight the different fixed income exposures.

"We respect the importance of keeping a longer-term outlook while still protecting against the risks of tomorrow." – Mitch Ehmka, Director of Trading and Co-Portfolio Manager

Many strategies try to be forward-looking, guessing where interest rates may be headed, or strictly investing in certain asset classes, regardless of the current interest rate or risk environment. Opportunity Income does not try to guess, but instead analyzes where we are in the interest rate cycle and invests in those securities that have historically performed well in those environments. The overall portfolio is adjusted once a month but keeps pace as economic conditions change.

Read more about Kingsview Investment Management's portfolio strategies at https://kingsviewim.com/strategy-cards/.

# # #

About Kingsview Partners

Kingsview Partners is a unique alternative in a crowded field of financial advisory offerings. The firm holds a simple belief that quality of service, knowledge of subject matter and fairness can all coalesce into a successful business. Dedication to their clients' welfare serves as a foundational trait, and one deeply entrenched within the cultural fabric of Kingsview. For many, the financial services industry has fallen dramatically short of meeting their needs, but Kingsview aims to do better and is dedicated to "Elevating the Standard of Care."

To achieve this mission, Kingsview Partners operates Kingsview Wealth Management, a fee-based, Registered Investment Advisor serving thousands of individual clients across the nation. Complementing the firm's advisory business is their full-service insurance agency, Kingsview Trust and Insurance Services. Finally, Kingsview Partners works to ensure clients have access to high-value, low-cost, professionally managed investments via Kingsview Investment Management, a standalone asset manager providing investment portfolios to meet nearly any client need.

# # #

Important Disclosures:

Kingsview Wealth Management ("KWM") is an investment adviser registered with the Securities and Exchange Commission ("SEC"). Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed.

Kingsview Investment Management ("KIM") is the internal portfolio management group of KWM. KIM asset management services are offered to KWM clients through KWM IARs. KIM asset management services are also offered to non KWM clients and unaffiliated advisors through model leases, solicitor agreements and model trading agreements. KWM clients utilizing asset management services provided by KIM will incur charges in addition to the KWM advisory fee.

This material has been prepared by Kingsview Wealth Management, LLC. It is not, and should not, be regarded as investment advice or as a recommendation regarding any particular security or course of action. Opinions expressed herein are current opinions as of the date appearing in this material only. All investments entail risks. There is no guarantee that investment strategies will achieve the desired results under all market conditions and each investor should evaluate their ability to invest for the long term. This information does not address individual situations and should not be construed or viewed as any typed of individual or group recommendation. Be sure to first consult with a qualified financial adviser, tax professional, and/or legal counsel before implementing any securities, investments, or investment strategies discussed.

The Bloomberg U.S. Aggregate Bond Total Return Index is an index designed to provide a measure of the performance of the U.S. investment grade bonds market, which includes investment grade U.S. Government bonds, investment grade corporate bonds, mortgage pass through-securities and asset-backed securities that are publicly offered for sale in the United States. The securities in the index must have at least 1 year remaining to maturity. In addition, the securities must be denominated in U.S. dollars and must be fixed rate, nonconvertible, and taxable.

Renee Goyeneche
Kingsview Partners
+1 541-237-7648
email us here
Visit us on social media:

Source: EIN Presswire